PDS Biotech raises up to $22.55M in PIPE led by Nant; Soon-Shiong to join board

PDS Biotechnology Corp

PIPE raises up to $22.55M: $11.55M initial closing at $0.2825/unit, plus $11M milestone (Nant $10M, AB Group $1M) upon Phase 3 protocol submission.
Nant Capital led; Dr. Patrick Soon-Shiong to join board; Nant gets right to designate 2 directors while owning ≥15%.
Proceeds to repay debt and fund development; PDS0301 Phase 2 data in MSS/pMMR mCRC showed 80% survival at 24 months.
Company grants NantWorks 1-year exclusive option to negotiate license for PDS0101; board expands from 6 to 8.
Common warrants exercisable at $0.22/share for 1 year; pre-funded warrants at $0.00033; 19.9% beneficial ownership cap.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.